70% Revenue Growth for Nvidia Next Year May Make It the Best Stock to Buy In the Market

The article argues Nvidia could nearly double from about $230 to nearly $460 per share if it delivers management's indicated 70% revenue growth next fiscal year. Using Wall Street's current-year EPS estimate of $9.31, it projects roughly $15.83 of EPS next year and applies Nvidia's current 29x P/E multiple. The bullish thesis relies on persistent AI-budget expansion, memory-chip supply constraints, and the view that Nvidia's guidance has historically been conservative, though it is opinion-based rather than a new company announcement.

Analysis

The central underwriting error is treating revenue growth as mechanically equivalent to EPS growth. At NVDA's scale, accelerator mix, customer concentration, networking attach, memory availability, and the pace of new-product ramps can move gross margin and operating leverage materially; a revenue beat accompanied by lower gross-margin guidance would likely compress the multiple rather than produce the implied upside. The cited annual outlook also requires transcript-level verification: NVDA typically guides quarterly, so investors should distinguish formal guidance from management commentary or an extrapolated estimate before assigning it valuation significance.

If AI-system demand remains supply-limited, the less crowded beneficiary is the memory and manufacturing bottleneck rather than the GPU designer alone. MU has the clearest listed sensitivity to tighter HBM pricing and qualification volumes, while TSM benefits from advanced-node and packaging utilization; both can capture incremental economics even if customers defer complete rack deliveries. Conversely, a shortage can create a near-term opening for AMD and custom ASIC providers only if NVDA cannot allocate enough systems to strategic customers—making a simplistic NVDA-long/AMD-short pair vulnerable.

The next 1-3 month catalyst path is bookings visibility, gross-margin trajectory, and evidence that hyperscaler capex converts into deployed clusters rather than inventory. Over 6-18 months, the key risk is that AI spending shifts from training capacity to lower-cost inference architectures, reducing NVDA's system-level pricing power before revenue decelerates. Consensus may be underestimating near-term supply economics, but the promotional framing likely underestimates how quickly a premium multiple can de-rate if the first deceleration coincides with a margin reset.

Key Decisions for Investors

• Do not add directional NVDA exposure solely on the stated annual-growth claim; verify the primary earnings-call transcript and consensus revenue/EPS bridge first. Treat any mismatch between formal quarterly guidance and the article's annual figure as a no-trade trigger.
• If verified bookings and next-quarter gross-margin guidance support sustained acceleration, initiate a 3-6 month long NVDA / short SOXX pair at 1:1 beta-adjusted notional. The thesis is share and software/networking attach, not broad semiconductor beta; exit if NVDA guides gross margin down by more than 200bp or relative performance lags SOXX by 10%.
• Build a 6-12 month watch-position long MU versus short SOXX following HBM pricing or supply-allocation confirmation. This expresses the bottleneck economics with less dependence on NVDA's terminal valuation; invalidate on falling HBM contract prices, weaker data-center DRAM bit growth, or material new qualified supply.
• For existing NVDA longs, replace part of outright exposure with a 6-9 month 10% out-of-the-money call spread financed by selling a 25-30% out-of-the-money call, rather than underwriting an unconstrained doubling scenario. Reassess after each earnings release on order backlog, networking attach, and gross-margin guidance rather than headline revenue growth.